Cargando…
Glutamate plasticity woven through the progression to alcohol use disorder: a multi-circuit perspective
Glutamate signaling in the brain is one of the most studied targets in the alcohol research field. Here, we report the current understanding of how the excitatory neurotransmitter glutamate, its receptors, and its transporters are involved in low, episodic, and heavy alcohol use. Specific animal beh...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000Research
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5365217/ https://www.ncbi.nlm.nih.gov/pubmed/28413623 http://dx.doi.org/10.12688/f1000research.9609.1 |
_version_ | 1782517477508382720 |
---|---|
author | Hwa, Lara Besheer, Joyce Kash, Thomas |
author_facet | Hwa, Lara Besheer, Joyce Kash, Thomas |
author_sort | Hwa, Lara |
collection | PubMed |
description | Glutamate signaling in the brain is one of the most studied targets in the alcohol research field. Here, we report the current understanding of how the excitatory neurotransmitter glutamate, its receptors, and its transporters are involved in low, episodic, and heavy alcohol use. Specific animal behavior protocols can be used to assess these different drinking levels, including two-bottle choice, operant self-administration, drinking in the dark, the alcohol deprivation effect, intermittent access to alcohol, and chronic intermittent ethanol vapor inhalation. Importantly, these methods are not limited to a specific category, since they can be interchanged to assess different states in the development from low to heavy drinking. We encourage a circuit-based perspective beyond the classic mesolimbic-centric view, as multiple structures are dynamically engaged during the transition from positive- to negative-related reinforcement to drive alcohol drinking. During this shift from lower-level alcohol drinking to heavy alcohol use, there appears to be a shift from metabotropic glutamate receptor-dependent behaviors to N-methyl-D-aspartate receptor-related processes. Despite high efficacy of the glutamate-related pharmaceutical acamprosate in animal models of drinking, it is ineffective as treatment in the clinic. Therefore, research needs to focus on other promising glutamatergic compounds to reduce heavy drinking or mediate withdrawal symptoms or both. |
format | Online Article Text |
id | pubmed-5365217 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | F1000Research |
record_format | MEDLINE/PubMed |
spelling | pubmed-53652172017-04-14 Glutamate plasticity woven through the progression to alcohol use disorder: a multi-circuit perspective Hwa, Lara Besheer, Joyce Kash, Thomas F1000Res Review Glutamate signaling in the brain is one of the most studied targets in the alcohol research field. Here, we report the current understanding of how the excitatory neurotransmitter glutamate, its receptors, and its transporters are involved in low, episodic, and heavy alcohol use. Specific animal behavior protocols can be used to assess these different drinking levels, including two-bottle choice, operant self-administration, drinking in the dark, the alcohol deprivation effect, intermittent access to alcohol, and chronic intermittent ethanol vapor inhalation. Importantly, these methods are not limited to a specific category, since they can be interchanged to assess different states in the development from low to heavy drinking. We encourage a circuit-based perspective beyond the classic mesolimbic-centric view, as multiple structures are dynamically engaged during the transition from positive- to negative-related reinforcement to drive alcohol drinking. During this shift from lower-level alcohol drinking to heavy alcohol use, there appears to be a shift from metabotropic glutamate receptor-dependent behaviors to N-methyl-D-aspartate receptor-related processes. Despite high efficacy of the glutamate-related pharmaceutical acamprosate in animal models of drinking, it is ineffective as treatment in the clinic. Therefore, research needs to focus on other promising glutamatergic compounds to reduce heavy drinking or mediate withdrawal symptoms or both. F1000Research 2017-03-21 /pmc/articles/PMC5365217/ /pubmed/28413623 http://dx.doi.org/10.12688/f1000research.9609.1 Text en Copyright: © 2017 Hwa L et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Hwa, Lara Besheer, Joyce Kash, Thomas Glutamate plasticity woven through the progression to alcohol use disorder: a multi-circuit perspective |
title | Glutamate plasticity woven through the progression to alcohol use disorder: a multi-circuit perspective |
title_full | Glutamate plasticity woven through the progression to alcohol use disorder: a multi-circuit perspective |
title_fullStr | Glutamate plasticity woven through the progression to alcohol use disorder: a multi-circuit perspective |
title_full_unstemmed | Glutamate plasticity woven through the progression to alcohol use disorder: a multi-circuit perspective |
title_short | Glutamate plasticity woven through the progression to alcohol use disorder: a multi-circuit perspective |
title_sort | glutamate plasticity woven through the progression to alcohol use disorder: a multi-circuit perspective |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5365217/ https://www.ncbi.nlm.nih.gov/pubmed/28413623 http://dx.doi.org/10.12688/f1000research.9609.1 |
work_keys_str_mv | AT hwalara glutamateplasticitywoventhroughtheprogressiontoalcoholusedisorderamulticircuitperspective AT besheerjoyce glutamateplasticitywoventhroughtheprogressiontoalcoholusedisorderamulticircuitperspective AT kashthomas glutamateplasticitywoventhroughtheprogressiontoalcoholusedisorderamulticircuitperspective |